Why the most effective leaders aren't trying to reduce AI uncertainty, but are using it to move faster, make better decisions and unlock momentum while others stall in planning and hesitation.
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?
Bond investors are expected to scrutinize the results of critical local elections on Thursday as the war in the Middle East adds inflation pressure on the government.
No need to worry. Enter your e-mail address in the field below and we’ll email you a recovery link.
We offer two types of profiles – for employers and for job seekers. Please choose your type.
By continuing to use this website, you accept our Cookies policy
